WO2020243677A1 - Appareil et procédé de rétablissement de la santé par l'intermédiaire d'un champ énergétique - Google Patents
Appareil et procédé de rétablissement de la santé par l'intermédiaire d'un champ énergétique Download PDFInfo
- Publication number
- WO2020243677A1 WO2020243677A1 PCT/US2020/035469 US2020035469W WO2020243677A1 WO 2020243677 A1 WO2020243677 A1 WO 2020243677A1 US 2020035469 W US2020035469 W US 2020035469W WO 2020243677 A1 WO2020243677 A1 WO 2020243677A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patient
- enclosure
- baffle
- energetic
- gas
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 16
- 239000011521 glass Substances 0.000 claims abstract description 13
- 230000003340 mental effect Effects 0.000 claims abstract description 9
- 239000002985 plastic film Substances 0.000 claims abstract description 5
- 239000002759 woven fabric Substances 0.000 claims abstract description 5
- 230000002996 emotional effect Effects 0.000 claims abstract description 3
- 230000035876 healing Effects 0.000 claims description 8
- 239000002105 nanoparticle Substances 0.000 claims description 3
- 238000009223 counseling Methods 0.000 claims description 2
- 238000012800 visualization Methods 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 10
- 239000002184 metal Substances 0.000 abstract description 2
- 229910052751 metal Inorganic materials 0.000 abstract description 2
- 210000000056 organ Anatomy 0.000 description 23
- 238000001467 acupuncture Methods 0.000 description 17
- 230000005540 biological transmission Effects 0.000 description 16
- 230000033001 locomotion Effects 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 7
- 230000005484 gravity Effects 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000008602 contraction Effects 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000035939 shock Effects 0.000 description 5
- 210000000115 thoracic cavity Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000005672 electromagnetic field Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000013467 fragmentation Methods 0.000 description 4
- 238000006062 fragmentation reaction Methods 0.000 description 4
- 239000005433 ionosphere Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 208000008558 Osteophyte Diseases 0.000 description 3
- 230000001133 acceleration Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000003990 capacitor Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 230000001143 conditioned effect Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000036284 oxygen consumption Effects 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000009987 spinning Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- KRQUFUKTQHISJB-YYADALCUSA-N 2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one Chemical compound CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1 KRQUFUKTQHISJB-YYADALCUSA-N 0.000 description 2
- 208000022497 Cocaine-Related disease Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 2
- 235000019892 Stellar Nutrition 0.000 description 2
- 201000006145 cocaine dependence Diseases 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000013213 extrapolation Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000002297 mitogenic effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- JAPJOLBDXOXSKE-WQICJITCSA-N (2s)-2-[[(2s)-2-[[(e)-3-(furan-2-yl)prop-2-enoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)\C=C\C=1OC=CC=1)C1=CC=CC=C1 JAPJOLBDXOXSKE-WQICJITCSA-N 0.000 description 1
- LPLLVINFLBSFRP-UHFFFAOYSA-N 2-methylamino-1-phenylpropan-1-one Chemical compound CNC(C)C(=O)C1=CC=CC=C1 LPLLVINFLBSFRP-UHFFFAOYSA-N 0.000 description 1
- 208000000058 Anaplasia Diseases 0.000 description 1
- 201000007848 Arts syndrome Diseases 0.000 description 1
- 101800005049 Beta-endorphin Proteins 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 102100025841 Cholecystokinin Human genes 0.000 description 1
- 101800001982 Cholecystokinin Proteins 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 241000608781 Eptesicus serotinus Species 0.000 description 1
- 241001125671 Eretmochelys imbricata Species 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- YFGBQHOOROIVKG-FKBYEOEOSA-N Met-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 YFGBQHOOROIVKG-FKBYEOEOSA-N 0.000 description 1
- 108010042237 Methionine Enkephalin Proteins 0.000 description 1
- 206010027603 Migraine headaches Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 208000000491 Tendinopathy Diseases 0.000 description 1
- 206010043255 Tendonitis Diseases 0.000 description 1
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037086 body physiology Effects 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940107137 cholecystokinin Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000009474 immediate action Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910001872 inorganic gas Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000005610 quantum mechanics Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 230000022379 skeletal muscle tissue development Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 201000004415 tendinitis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 238000009424 underpinning Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/16—Screening or neutralising undesirable influences from or using, atmospheric or terrestrial radiation or fields
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0055—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with electric or electro-magnetic fields
Definitions
- the instant invention relates to a device and process designed to aid an ailing individual’s body to heal itself.
- Figure 1 depicts a lightning bolt.
- F igure 2 depicts a T esla device to converge the harmonic energy from four independent series resonant circuits.
- Figure 3 depicts the superluminal propagation of the Coulombic field from Obolensky’s Miniature Magnifying Transmission of superluminal energy propagation shown in the Coulombic currents detected by identical antenna systems.
- Figure 4 depicts Obolensky’s miniature Tesla Magnifying Transmission Instrument treatment room. Electro-magnetic shock waves in a controlled non-linear environment creates a phase-conjugate (time-reversal) replica, resonating with the human electro-magnetic field (human aura). It’s use for the body’s mitogenic entropy reduction has implications for medicine and science.
- Figure 5 is a diagram drawn inside the Negative Ion generator room reflecting the Traditional Chinese Medicine meridians and points of the Heart, Triple Warmer, Ren( thoracic), Ear and Nose points. Note the second thoracic picture appears to be the Yoga chakras 5.
- Figure 6 depicts the synchronization of brain waves during meditation.
- Figure 7 depicts a chart comparing oxygen consumption during Zen meditation and during sleep.
- Figure 8 depicts blood-lactate changes associated with Zen meditation.
- Figure 9 shows the contraction and expansion of an acupuncture area.
- Figure 10 depicts the transverse quanta of energy entering and moving in many directions.
- Figure 11 depict various internal and external practices whereby Universal Qi (density matrix non zero matter and spin 1) can be accessed through practices of bringing in outside universal Qi through the breath.
- Universal Qi density matrix non zero matter and spin 1
- Figure 12 depicts the internal and external features of the treatment device.
- Figure 13 depicts an oscilloscope image measuring light speed from co axial sensors within the miniature Tesla Magnifying Transmission in 2004. This shows a superluminal velocity, then variations in speed.
- a device and process are designed to aid an ailing individual’s body to heal itself.
- the patient is put in a more receptive state to benefit from the healing process.
- the patient is placed within a metallic(e.g., copper)-lined enclosure (essentially a Faraday cage) and placed in a comfortable and/or therapeutically beneficial position, seated, reclining, standing or otherwise.
- a metallic(e.g., copper)-lined enclosure essentially a Faraday cage
- the patient enclosure is maintained at or near a temperature of 90 degrees F, and at or near a relative humidity of 85%.
- the energy emitted from the tube is directed toward a dome or circular concave baffle covered in a densely woven fabric which disperses an energetic field within the enclosure.
- a plastic sheet optionally with embedded nano-particles, is optionally placed between the dome and the patient to eliminate potential arcing between the dome and the patient.
- the energy field thus created inside the room assists the patient’s own natural energetic properties (e.g., Qi) to promote a restoration of a healthy and balanced state.
- the body’s tendency to achieve self-healing i.e., restore a state of properly balanced and free flowing energy
- immersion in this field in ways that are similar to those promoted by practitioners of healing arts such as acupuncture, medical acupuncture, deep needling, Qigong, and the like.
- Seating or other supports are provided within the patient enclosure to enable proper positioning of the patent so that the energy emitted from the tube can be directed toward the area to be treated.
- Seating is optionally provided for the practitioner/therapist to accompany the patient during therapy, to provide proper alignment of the patient and the apparatus. And, also to provide to the patient, mental and emotional guidance, in order to promote optimal receptivity of benefit by the patient.
- Figure 12 depicts the preferred embodiment of the instant invention comprising:
- Element 1200 an external enclosure of the treatment device, the walls, floor and ceiling of which are composed of a layer of metal (e.g., copper) and a layer of an insulating material; Element 1201, a dielectric-oil-filled housing for electrical circuits; Element 1202, a glass gas-filled cylinder; Element 1203, a dome approximately 18 inches in diameter which is wrapped in tightly woven fabric; Element 1204 an opening for cylinder 1202 to pass from the housing 1201 through the wall of the enclosure into the enclosure 1200; Element 1205, a movable plastic screen separating the disc from the treatment area of the enclosure; Elements 1206, 1207 and 1208, a bench, chair and stool, respectively, any of which maybe placed in the enclosure to enable the particular area of the patient to be treated to be appropriately located in relation to the therapeutic field that is generated; Element 1209 optional seating for the person administering the therapy to the patient; and, Element 1210, sliding doors to allow entrance and egress to/from the enclosure.
- metal e.g., copper
- This moving aether thus contains (carries) a chaotic distribution of field-piloted extended solitons and wave elements, i.e., piloted solitons ⁇ ⁇ Soliton: Phase conjugate energy density, reciprocally orthogonal spin coupled rectilinear vibration of transverse Hertzian waves, double density 120 Pi (377 ohm) space impedance, the variable KdV energy density Solitary Wave equation determinates of space impedance. ⁇ (which can be describe by collective Maxwellian equations, locally invariant under SU ⁇ ) for vortices' filling this flat unlimited, three dimensional space. In Lorentz's model, observers, and measuring devices are both made up of aether elements. ⁇ lv! ⁇ v! ⁇ vi! ⁇ vil!
- the aether has density from the intersection of transverse and longitudinal fields or coulombic and gaussian field intersecting. ⁇ vm! This density can also be evaluated by the heaviness of rotating bodies the resistance offered to their rotation.
- the acceleration of gravity at the surface of a rotating body at its equator can be calculated from known values of the gravitational force F and equatorial radius R e by
- Vg v (gR e )
- a measurement of the sidereal period given the actual velocity at the equator V e can then be calculated by the expression V e 2 /R.
- the ratio g/a e is a measurement of the rotating body's heaviness.
- inertia is the tendency of an object to maintain its state of uniform motion
- inertia can be described as a resistance to change of motion of a given body, so it is proportional to the body’s local weight W.
- W ma (a has superscript of - for inertia)
- This formula is confirmed by experiments that show that inertia is independent of the mass. This implies that the mass and its orbital rotation velocity vary when its velocity changes.
- the angular velocity w of Earth’s spin is not the same at perihelion (which occurs January 1-4), i.e. 6.231. 10 neg 3 m.s. neg. 2, and at aphelion (July 4-6), i.e., 5.6637.
- Photons are present only with transverse electromagnetic waves, and their energy-momentum is carried by photons and by waves.
- electrons are extended bilocal structures (made up of a hole and a bump in Dirac’ s aether), which contain different angular momentum around Y m and Cm, the latter surrounded by rotating charge and mass distributions.
- aether Localized photons and electrons elements are embedded in an aether, which moves in flat-space.
- the aether satisfies locally the laws of Special Relativity (with measurement instruments included) but their accelerated elements’ motions do not satisfy the laws of General Relativity and change their shape in accelerated motions (detected by real local, aether-built elements) in the flat space in which they move.
- This daily variation appears to be a function of the height of the ionosphere and solar activity. So long as the properties of Earth’s electromagnetic cavity remain the same, these frequencies remain the same. Presumably there is also variation due to the 11 -year solar activity cycle.
- An oversimplified idea of Tesla was to create an energy which skips on density matrix in the cavity of the earth with more energy emerging than was putt in.
- Figure 3 demonstrates superluminal propagation of the Coulombic field from Obolensky’s Miniature Magnifying Transmission of superluminal energy propagation shown in the Coulombic currents detected by identical antenna systems.
- the effect antenna’s 4.25’ distance from the dome (lower trace) should produce a 4.25 ns light speed delay.
- the observed coincidence of the dome’s causal earth-current indicates a superluminal velocity.
- Figure 13 constitutes another measurement that the inventor and Obolensky conducted in 2004 with slightly different oscilloscope setting.
- the wave starts with theoretically infinite speed, slowing down first very quickly and afterwards at a lesser rate... Only force is conveyed to all points of the earth, the energy itself traveling in definite paths determined beforehand, reaches the receiver without the lightest dispersion, so that an incomparably great amount is collected than is possible by radiation.”
- Tesla s patent application’s spherical wave phenomenology clearly parallels that envisioned by Louis de Broglie’s in his double solution theory.
- This miniature Tesla magnifying Transmitter is within 320 cubic-foot (8’x 8’ x5’) magnifying transmitter’s hermetic enclosure, at a temperature of 90° F and relative humidity of 85%, an apparent immediate temperature drop exceeding 9° F occurs upon impulse modulating the elliptical dome’s Coulombic Field.
- Obolensky used a Guilemin a-parameter, MathCAD, program which facilitated his design for the parabolic rise and fall, impulse modular needed to excite his 18’ diameter elliptical-dome electrode.
- This earth/air capacitor-electrode is held 5’ above its ground plain by the Diala-oil filler cylinder that contains and insulates the impulse modulator components.
- FIG. 4 shows Obolensky’s miniature Tesla Magnifying Transmission Instrument treatment room. Electro-magnetic shock waves in a controlled non-linear environment creates a phase-conjugate (time-reversal) replica, resonating with the human electro-magnetic field (our aura). It’s use for the body’s mitogenic entropy reduction has implications for medicine and science.
- thermodynamic equilibrium The warp and weft of this fabric is the accepted, thermodynamic equilibrium, entropy.
- time arrow points to increasing entropy and dispersion.
- the far from thermodynamic equilibrium Mach disk can reverse the direction of entropy flow so normal entropy and dispersion cancel. ⁇ xu!
- Evolved life utilizes immediate communication and information transmission.
- accepted science rej ects this immediate action at a distance contention because conventional thinking prefers the Abelian mathematics of the standard, Maxwellian, U (1) Gauge symmetry.
- This symmetry convention facilitated commercialization of light-speed limited, Transverse-Electro-Magnetic (TEM) Hertz-wave technology.
- TEM Transverse-Electro-Magnetic
- LEM Longitudinal-Electro-Magnetic
- Tesla-waves all require complex non-Abellian mathematics.
- thermodynamic-equilibrium macro-luminal Mach disk This effect was not realized until Prigogine won his Nobel Prize by proving that far from equilibrium thermodynamic process circumvent the second law of thermodynamic. In other words, as perfect information is normally lost over time all imperfect systems increase in entropy until they die. In this sense, disease is the immune systems inability to minimize entropy gain far from thermodynamic equilibrium.
- the negative-ion wind produced by Obolensky’s magnifying transmitter is created by a train of LEM solitons that negate otherwise entropic heat produced by the steam jets that keep the elliptic terminal wet.
- the ability of structured negative-ion wind to organize atmospheric water plays a significant role in the body’s physical health. The average person loses between one-eight and three quarters pounds of toxic sweat, while well hydrated persons have a lost 2 lbs. during a single treatment. Most remarkable several very dehydrated individuals have gained 2 pounds.
- Figure 5 was sketched by inventor while inside the Negative Ion generator room reflecting the Traditional Chinese Medicine meridians and points of the Heart, Triple Warmer, Ren( thoracic), Ear and Nose points. Note the second thoracic picture appears to be the Yoga chakras.
- Open circuits create illumination of acupuncture points and variation of beaming violet light. In complete darkness this equilibrium interaction can be seen activating the various acupuncture points on the surface of the skin.
- Individuals in contact with the instrument emanate white light from their fingers and toes and master acupuncture points throughout the body show approximate patterns, for example, the triple heater (posterior aspect of the forearm) or heart pathway points on the elbow and ulnar aspects of the arm. See Figure 5.
- On the torso variations show up, in one case small points all over the torso and in another patient approximate to the Indian’s yoga chakras.
- Beams of healing light play to and fro, directed entirely by the body’s electromagnetic interaction with nanosecond-period T esla-waves and the negative-ion wind they produce. Injuries, bone spurs, cancer tumors, diseased organs need no instruction from the instrument, positive ions in the body are bombarded with negative ions in a beam of variations of violet. (Szent-Gyorgyi 1988)
- Frohlich showed that when energy is supplied to such a system, either from metabolism or from external sources above a critical rate, it is automatically channeled into the lowers frequency mode, thereby resulting in coherent excitation of the vibratory components (a phenomenon known as Bose-Einstein condensation).
- Frohlich predicted, on the basis of quantum mechanics that the living matrix can produce laser-like coherent beams at many wavelengths including visible and near visible light that is radiated into the environment. These are not subtle phenomena they are large scale and their effects are not trivial. For example, living tissue is so highly organized that it can support the Bose-Einstein condensate and excitation of Frohlich resonance.
- Figures 6, 7 and 8 show the synchronization of brain waves during meditation; the comparison of oxygen consumption during Zen meditation and during sleep; and blood-lactate changes associated with Zen meditation, respectively, of a Zen Master meditator in the deepest states of meditation or the Bose-Einstein state.
- ⁇ ⁇ Two types of meditation will be discussed here, Involuntary like Zen meditation where one does not use the Will and voluntary muscles to move the breath and Qigong where volition or will is used to recruit the voluntary muscles.
- Afferent conditioning from outside trauma affects organ functioning and creates a lack of synchronization that is reactivated by approximation of original trauma based upon physiological experiments. How does one get to an unconditioned state and not knee-jerk reactivity to cultural and individual fragmentation, or not adapting to weather.?
- Curvilinear and transverse phenomenon can be seen in the very structure of the human skull, and the transverse up and down of the nervous (motor) system, immune system, blood (oxygenated and deoxygenated), and the in and out of the respiration of the cell and lungs.
- Organs and the heart can be conditioned to be out of synch by cultural and individual differences as well as habits of food and substance intake.
- Qigong meditation practice which resulted in a synchronization of body physiology in terminal phases of heart disease to increase heat, and calm an agitated state.
- men still did better than conventional addition therapy.
- a high-powered light on the finger nail shows an immediate vasodilation of the small capillaries.
- the heart and diaphragm have multiple phases and pathology happens when one phase is stuck or constricted. In the heart the thoracic rib cage locking, in the diaphragm, and the back of neck twisting. Life goes on but morbidity sets in.
- Figure 9 illustrates the contraction and expansion of the acupuncture area.
- Figure 10 illustrates the transverse quanta of energy entering and moving in many directions.
- organs are solid (liver, kidney, pancreas, heart) or hollow (gall bladder, bladder, stomach, lungs, large intestine and small intestine) with the hollow organs having transverse movement such as bile, water, food and digested food.
- the solid organs filter substances and the heart with its electro cardiac cells create rhythm for the arteries to contract and circulate blood.
- the heart has more than one direction, going up to the head and down to the body. Movement of de-oxygenated blood against gravity back into the heart and lungs through the veins is dependent upon body movement. Veins have trap doors to prevent backflow but need movement to overcome gravity.
- Gravity is a major impediment to blood circulation to the head (average 80-90 mmHg) and up from the feet (180-190 mmHG). Gravity and inertia define mass so impediment to energy flow is culture/outside/weather conditions habitual physiological functioning and mental habits. In other words, the dome acupuncture areas can get stuck in a phase with disease perpetuation and the body /mind as a whole conditioned and phase stuck. Inertia and stagnation create reactive condition of fragmentation or better put maintain condition.
- Qigong curvilinear and up and down transverse practices create a conjugate phase change and capture space filled substance defined as density matrix, uncreated, unformed and named here as Universal Qi or UQi.
- Our created form of the mind/body is conditioned and bifurcates into organ interaction dysfunction and mental fragmentation. In Zen meditation one just sits still for a long period and does nothing just waits, not attaching to thoughts, letting them go, then things settle over time, with no Will or volition.
- Qigong uses Will and internal practices to create Qi by synchronizing organs from fragmented yin and yang organ struggle by internal up and down with the breath. Humans have a left and right side and when one dominates, the spine suffers. This happens from spine tension (posture) which compromises enervation of the organs. Front and back go together. Hollow Organs are Yang and solid Yin. Together harmonized and create Qi. Qi creates the conjugate state phase change. This is not the normal state, mostly there is disequilibrium with pain and suffering with morbidity lurking. Qigong practices help create internal Qi from out of balance Yin and Yang organs.
- Figure 11 A is the microscopic external orbit.
- Figure 1 IB is gathering UQi externally.
- Figure 11C is the internal microscopic orbit to regulate Qi inside the body.
- Figure 1 ID is internal transverse meditation to regulate the fire organ, liver, with the lower water organ, bladder to harmonize.
- Figure 1 IE is transverse inner skull cavity meditation.
- Figure 1 IF is the practice of Ba Gua Yi Qui Gong which creates (Xin) information about the relationship between the Universe, Nature, and Humans. Curvature Sky/Yang and Rectilinear Earth Qi Yin harmony resides in the ball. The practice is with Yi intension and Nian mind (ling soul) focusing on the center of the ball, spinning it with palms shoulder width and ball from top of chest to waist. Left to right, up and down, around. (This is the essence of Tai Chi Chuan) This then creates a pattern that teaches Nature’s way of the circle and transverse processes. ⁇ xx v!
- Figure 11G is breathing in through all the pores from 360 degrees then entering the body traversing up and down the abdomen before breathing out again. This harmonizes the internal organs and brings in UQi and is curvilinear and transverse practice all at once.
- Figure 13 shows an oscilloscope image measuring light speed from co-axial sensors within the miniature Tesla Magnifying Transmission in 2004. This shows a superluminal velocity, then variations in speed.
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Radiation-Therapy Devices (AREA)
- Percussion Or Vibration Massage (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202080055246.2A CN116096329A (zh) | 2019-05-30 | 2020-05-30 | 通过能量场恢复健康的装置和方法 |
JP2021571350A JP2022535232A (ja) | 2019-05-30 | 2020-05-30 | エネルギー場を介して健康を回復するための装置及び方法 |
KR1020217042952A KR20220016175A (ko) | 2019-05-30 | 2020-05-30 | 에너지장을 통해 건강을 회복하기 위한 장치 및 방법 |
CA3142422A CA3142422A1 (fr) | 2019-05-30 | 2020-05-30 | Appareil et procede de retablissement de la sante par l'intermediaire d'un champ energetique |
EP20815374.2A EP3976173A4 (fr) | 2019-05-30 | 2020-05-30 | Appareil et procédé de rétablissement de la santé par l'intermédiaire d'un champ énergétique |
MX2021014556A MX2021014556A (es) | 2019-05-30 | 2020-05-30 | Aparato y metodo para restaurar la salud a traves del campo energetico. |
AU2020283059A AU2020283059A1 (en) | 2019-05-30 | 2020-05-30 | Apparatus and method for restoring heath via energetic field |
IL288540A IL288540A (en) | 2019-05-30 | 2021-11-30 | Device and method for preserving health using an energy field |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962921070P | 2019-05-30 | 2019-05-30 | |
US62/921,070 | 2019-05-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2020243677A1 true WO2020243677A1 (fr) | 2020-12-03 |
WO2020243677A9 WO2020243677A9 (fr) | 2021-01-28 |
Family
ID=73552431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2020/035469 WO2020243677A1 (fr) | 2019-05-30 | 2020-05-30 | Appareil et procédé de rétablissement de la santé par l'intermédiaire d'un champ énergétique |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3976173A4 (fr) |
JP (1) | JP2022535232A (fr) |
KR (1) | KR20220016175A (fr) |
CN (1) | CN116096329A (fr) |
AU (1) | AU2020283059A1 (fr) |
CA (1) | CA3142422A1 (fr) |
IL (1) | IL288540A (fr) |
MX (1) | MX2021014556A (fr) |
WO (1) | WO2020243677A1 (fr) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040210289A1 (en) * | 2002-03-04 | 2004-10-21 | Xingwu Wang | Novel nanomagnetic particles |
US20050249667A1 (en) * | 2004-03-24 | 2005-11-10 | Tuszynski Jack A | Process for treating a biological organism |
US20060241333A1 (en) | 2005-04-21 | 2006-10-26 | Ksm, Inc. | Electromagnetic treatment device |
US7479101B2 (en) | 2005-04-21 | 2009-01-20 | Ksm, Inc. | Method for treating an animal using a constant amplitude electromagnetic field |
US20110190569A1 (en) * | 2009-03-20 | 2011-08-04 | ElectroCore, LLC | Non-invasive methods and devices for inducing euphoria in a patient and their therapeutic application |
US20120209052A1 (en) * | 2008-05-22 | 2012-08-16 | Vladimir Balakin | Magnetic field control method and apparatus used in conjunction with a charged particle cancer therapy system |
US20130261711A1 (en) * | 2008-07-16 | 2013-10-03 | Frank Sivo | Methods to arrest cancer cell growth and proliferation using electromagnetic energy delivered via electromagnetic coil systems |
US20140343642A1 (en) | 2013-05-14 | 2014-11-20 | Vincent Lauer | Device for treating diseases |
US20170181894A1 (en) * | 2012-05-15 | 2017-06-29 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
US20170326357A1 (en) | 2014-10-03 | 2017-11-16 | NEUROSPRING, Inc. | Deep nerve stimulator |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104941071B (zh) * | 2015-05-06 | 2017-07-11 | 青岛市第三人民医院 | 神经内科偏头痛治疗装置 |
CN104825271B (zh) * | 2015-05-18 | 2017-01-25 | 李建华 | 耳鼻喉疾病治疗装置 |
CN106237529A (zh) * | 2016-08-17 | 2016-12-21 | 安会泳 | 一种通过人体量子效应治疗疾病的治疗室及系统 |
CN109381793A (zh) * | 2018-05-02 | 2019-02-26 | 罗放明 | 一种射频能量、生命能谱医疗装置 |
-
2020
- 2020-05-30 AU AU2020283059A patent/AU2020283059A1/en active Pending
- 2020-05-30 CN CN202080055246.2A patent/CN116096329A/zh active Pending
- 2020-05-30 MX MX2021014556A patent/MX2021014556A/es unknown
- 2020-05-30 CA CA3142422A patent/CA3142422A1/fr active Pending
- 2020-05-30 JP JP2021571350A patent/JP2022535232A/ja active Pending
- 2020-05-30 WO PCT/US2020/035469 patent/WO2020243677A1/fr unknown
- 2020-05-30 KR KR1020217042952A patent/KR20220016175A/ko unknown
- 2020-05-30 EP EP20815374.2A patent/EP3976173A4/fr active Pending
-
2021
- 2021-11-30 IL IL288540A patent/IL288540A/en unknown
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040210289A1 (en) * | 2002-03-04 | 2004-10-21 | Xingwu Wang | Novel nanomagnetic particles |
US20050249667A1 (en) * | 2004-03-24 | 2005-11-10 | Tuszynski Jack A | Process for treating a biological organism |
US20060241333A1 (en) | 2005-04-21 | 2006-10-26 | Ksm, Inc. | Electromagnetic treatment device |
US7479101B2 (en) | 2005-04-21 | 2009-01-20 | Ksm, Inc. | Method for treating an animal using a constant amplitude electromagnetic field |
US20120209052A1 (en) * | 2008-05-22 | 2012-08-16 | Vladimir Balakin | Magnetic field control method and apparatus used in conjunction with a charged particle cancer therapy system |
US20130261711A1 (en) * | 2008-07-16 | 2013-10-03 | Frank Sivo | Methods to arrest cancer cell growth and proliferation using electromagnetic energy delivered via electromagnetic coil systems |
US20110190569A1 (en) * | 2009-03-20 | 2011-08-04 | ElectroCore, LLC | Non-invasive methods and devices for inducing euphoria in a patient and their therapeutic application |
US20170181894A1 (en) * | 2012-05-15 | 2017-06-29 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
US20140343642A1 (en) | 2013-05-14 | 2014-11-20 | Vincent Lauer | Device for treating diseases |
US20170326357A1 (en) | 2014-10-03 | 2017-11-16 | NEUROSPRING, Inc. | Deep nerve stimulator |
Non-Patent Citations (28)
Title |
---|
A. EINSTEIN, ANN. D. PHYS., vol. 17, 1905, pages 891 |
A.A. VOLOKHOV: "On the Significance of Various Levels of the Central Nervous System in the Formation and Development of Motor Reaction in Embryogenesis", PLZEN. LEK. SBOR., vol. 3, 1961, pages 141 - 145 |
A.G. OBOLENSKYJ.P. VIGIER: "Preliminary observation of the superluminal propagation of the Coulombic field support Lorentz's interpretation of Special Relativity Theory", WHOLE PERSON HEALING INSTITUTE, INC. BLUE PAPER |
A.R. LURIA.: "The Problem of the Cultural Behavior of the Child.", FROM THE PSYCHOLOGICAL LABORATORIES OF THE AKADEMII KOMMUNISTICHESKOGA FOSPIITANIYU IM. N.K. KRUPSKAI JOURNAL OF GENETIC PSYCHOLOGY, vol. 35, 1928 |
ALEXANDER GUY OBOLENSKYPHILLIP SHINNICKJOSEPH P. MAIZE: "A New Multidisciplinary Approach to Electro-Medicine Research", JOUR SCI HEAL OUT., vol. 4, no. 14-15, 2012 |
B. MARGON, PHYSICS TODAY, vol. 7, 1960, pages 26 |
B. MARGON, SC. AM., vol. 243, no. 4, 1980, pages 44 |
C.K. THORNHILL.: "The Kinetic Theory of Electromagnetic Radiation", SPECULATIONS IN SCIENCE AND TECHNOLOGY, vol. 8, no. 4, pages 263 - 272 |
CHEN, K, ZIEDUNIS, D. COMERFORD, A, SHINNICK, P.: "A Pilot Study oflntroducingQi-Meditation Therapy into Addiction Treatment", JOURNAL OF ADDICTIVE DISEASES, 2005 |
GUY OBOLENSKY AND P. SHINNICK: "Basics of Toroidal Spin Shock Waves", HEALTH SUMMIT AND SECOND QIGONG SUMMIT, BALTIMORE, MARHLAND, 14 April 2005 (2005-04-14) |
H.A. LORENTZ, PROC. ACA. SCI. ARNST., vol. 6, 1904, pages 809 |
J. HADDADG OBOLENSKYP. SHINNICK.: "The Biological Effects and the Therapeutic Mechanism-of-Action ofElectric and Electromagnetic Field Stimulation on bone and cartilage: New findings and a Review of Earlier Work.", JOUR OF ALT AND COM MED., June 2010 (2010-06-01) |
J.P. VIGIER, PHY. LETT. A, vol. 235, 1997, pages 419 |
K. M. BYKOVG.Y. VLADIMIROVV.Y. DELOVG.P. ET AL.: "Text-Book of Physiology, Foreign Languages Publishing House", MOSCOW, 1958 |
LOUIS DE BROGLIE, CAHIERS DE PHYSIQUE, no. 147, October 1962 (1962-10-01), pages 425 - 445 |
M.V. MESQUITAA.R. VASCONCELLOSR. LUZZI.: "Considerations on Undistorted-Progressive X-waves and Davydov Solitons, Frohlick-Bose-Einstein Condensation, and Cherenko-like Effect in Biosystems", BRAZILIAN JOURNAL OF PHYSIDS, vol. 34, 2 June 2004 (2004-06-02) |
N. SHARKEYG OBOLENSKYJ. HADDADP. SHINNICK: "Electric and Electromagnetic Field Stimulation Management of A Complex Ovarian Cyst A Case Report", JOURNAL OF REPRODUCTIVE MEDICINE, 2010 |
N.A. KOZYREV.: "Possibility of Experimental Study of the Properties of Time", JOINT PUBLICATION RESEARCH SERVICE. 1000 NORTH GLEBE ROAD, ARLINGTON, VIRGINIA. 22201 |
P. SHINNICKL. PORTER: "Whole Person Self-Healing: A Science and Art. Bentham", 2017, SCIENTIFIC PUBLISHERS. UAE. |
P. SHINNICKS. FREED.: "Organic Life energy in Physiological States of Chan) or Zen) Buddhism and Inorganic Analogous States oF Super Fluid Helium Liquid", JORN SCI HEA OUTCOMES., vol. 3, no. 12, July 2011 (2011-07-01) |
P. SHINNICKS.FREED.: "A Case Study of the Synchronization of Human Energy in an Acute Condition of Chronic Heart Disease Through Complementary Treatment", SUB ENER & ENER MED., vol. 13, no. 3, 2004 |
P. SHINNNICK AND A. BORGNA.: "Whole Person Healing The O-RingimagingTechnique Influences to Oriental and Occidental Medicine", AUTHORHOUSE. BLOOMINTON, IND., 2009 |
P. SPOLTER.: "Gravitational Force of the Sun.", vol. 11862, 1993, ORB. PUBLISHING CO. |
R. ANTANASIJEVICR. BANJANACA. DRAGIC ET AL.: "Gravitation et Cosmologie Relativites. Tour", INSTITUTE OF PHYSICS, article "On the Electrical Discharge in Air." |
See also references of EP3976173A4 |
T. CAREY, WHICH SPECIAL RELATIVITY IS CORRECT-EINSTEIN'S OR LORENTZ'S?, 1998 |
T.V FLANDERNJ.P.: "Vigier Experimental Repeal of the Speed Limit for Gravitational electrodynamic, and Quantum Field Interaction", FOUNDATION OF PHYSICS, vol. 32, no. 7, July 2002 (2002-07-01) |
W. LI PING.: "Ling Bao Tong Zhi Neng Nei Gong Shu." |
Also Published As
Publication number | Publication date |
---|---|
CN116096329A (zh) | 2023-05-09 |
AU2020283059A1 (en) | 2022-01-27 |
KR20220016175A (ko) | 2022-02-08 |
MX2021014556A (es) | 2022-04-06 |
JP2022535232A (ja) | 2022-08-05 |
WO2020243677A9 (fr) | 2021-01-28 |
CA3142422A1 (fr) | 2020-12-03 |
EP3976173A4 (fr) | 2023-06-14 |
EP3976173A1 (fr) | 2022-04-06 |
IL288540A (en) | 2022-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Macklis | Magnetic healing, quackery, and the debate about the health effects of electromagnetic fields | |
Ho et al. | Bioelectrodynamics and biocommunication | |
Moini | Anatomy and physiology for health professionals | |
Becker | Six pillars of energy medicine: Clinical strengths of a complementary paradigm | |
Romanella et al. | Noninvasive brain stimulation & space exploration: opportunities and challenges | |
Nokes et al. | Introduction to medical electronics applications | |
Zhou et al. | Bioelectrodynamics in living organisms | |
US11771894B2 (en) | Apparatus and method for restoring health via energetic field | |
Tansley | Radionics interface with the Ether-Fields | |
WO2020243677A9 (fr) | Appareil et procédé de rétablissement de la santé par l'intermédiaire d'un champ énergétique | |
Shinnick | DUAL PROPERTIES OF ELECTROMAGNETIC LIGHT: THE CURVILINEAR (OCTAGONAL) AND RECTILINEAR IN THE COSMOS, EARTH AND APPLICATIONS FOR MEDICINE AND DISEASE | |
Raines | Electromagnetic field interactions with the human body: Observed effects and theories | |
Pitkänen | Magnetospheric Sensory Representations | |
Waechter | Qi and bioelectromagnetic energy | |
Nahas et al. | The Quantum Body | |
H. Maurer et al. | Advances in space technology: the NSBRI technology development team | |
Gardner | Vibrational Healing Through the Chakras: With Light, Color, Sound, Crystals, and Aromatherapy | |
Unschuld | The Reception of Oriental Medicine in the West Changing World View and Epistemological Adaptation | |
McReynolds | Energy Man-Energy Medicine | |
Hessenbruch | X-rays for medical use | |
Shinnick | InternalAlchemyand Bodily Energy Flow | |
Strakhova | The Body as an Electronic Scheme | |
Kanter | Energy, Therapy and Touch Foundation for the Healing Interaction | |
Abrams | New Concepts in Diagnosis and Treatment: Physico Clinical Medicine | |
Michrowski | 3 The Quantum Nature of Vitality |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20815374 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2021571350 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 3142422 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20217042952 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2020815374 Country of ref document: EP Effective date: 20220103 |
|
ENP | Entry into the national phase |
Ref document number: 2020283059 Country of ref document: AU Date of ref document: 20200530 Kind code of ref document: A |